Glucagon regulates lipolysis and fatty acid oxidation through inositol triphosphate receptor 1 in the liver-Reference-Cited by-同舟云学术

Glucagon regulates lipolysis and fatty acid oxidation through inositol triphosphate receptor 1 in the liver

Published:2020-07-26 Issue:1 Volume:12 Page:32-34
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J. Diabetes Investig.

Author:

Hayashi Yoshitaka¹^ORCID

Affiliation:

1. Department of Endocrinology Division of Stress Adaptation and Protection Research Institute of Environmental Medicine Nagoya University Nagoya Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13315

Reference5 articles.

1. Glutaminostatin: Another facet of glucagon as a regulator of plasma amino acid concentrations

2. Regulation of Lipolysis in Adipocytes

3. Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis

4. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones

5. Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary effects of Sclerocarya birrea caffra seed cake replacing soyabean meal on physiology, meat and bone quality of indigenous chickens;Veterinary and Animal Science;2024-09

2. Transgenic female mice producing trans 10, cis 12-conjugated linoleic acid present excessive prostaglandin E2, adrenaline, corticosterone, glucagon, and FGF21;Scientific Reports;2024-05-30

3. Pump‐Less, Recirculating Organ‐on‐Chip (rOoC) Platform to Model the Metabolic Crosstalk between Islets and Liver;Advanced Healthcare Materials;2024-02-09

4. Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial;Diabetologia;2023-12-14

5. A GLP1-receptor-agonistáktól a glükagonreceptor-agonizmussal kiegészített hármashormonreceptor-aktiválásig.;Orvosi Hetilap;2023-10-22